Research has demonstrated that the HBVM-BTLA signaling pathway plays an important role in cancer (14, 61), intestinal inflammation (12), autoimmune diseases (4, 13), viral infection (62), transplant rejection (11, 63), and in continuous chronic HBV infection. This evidence concerns the gene BTLA and autoimmune disease.